Locana logo

Locana Funding & Investors

Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

locanabio.com

Total Amount Raised: $155,550,000

Locana Funding Rounds

  • Series B

    $100,000,000

    Series B Investors

    Vida Ventures
    Temasek Holdings
    Lightstone Ventures
    Ra Capital Management
    Leerink Swann
    Invus
    GV
    Acuta Capital Partners
    Arch Venture Partners
    UCB Ventures
  • Grant

    $550,000

    Grant Investors

    Muscular Dystrophy Association
  • Series A

    $55,000,000

    Series A Investors

    Arch Venture Partners
    UCB Ventures
    Lightstone Ventures
    Temasek Holdings
    GV
Funding info provided by Diffbot.